Its design incorporates specific modifications to enhance metabolic stability and prolong half-life: Amino Acid Sequence: His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH Modifications: Substitution of alanine at position 8 with -aminoisobutyric acid (Aib) to confer resistance against dipeptidyl peptidase-4 (DPP-4) degradation. Acylation of the -amino group of Lys20 with a C18 fatty diacid via a -glutamic acid spacer and two units of 8-amino-3,6-dioxaoctanoic acid (ADO), enhancing albumin binding and extending plasma half-life. These structural features necessitate meticulous analytical techniques to confirm the integrity and consistency of Semaglutide batches. Peptide Sequencing of Semaglutide resource: Impact of Lipidation on Analytical Performance The lipidation strategy employed in Semaglutide significantly alters its physicochemical behavior during analytical testing
Step 5: Label the vial with the date of reconstitution, the concentration (e.g., "10mg in 3mL = 3.33mg/mL"), and the 28-day expiration date
42.7 ms) of AXA1125 decreased more significantly
Symptoms include trembling, sweating, confusion, palpitations, hunger, and irritability
Conforms to international standards (DIN-ISO 3585), this 20ml vial is a great choice for laboratory and research applications, ensuring reliability and safety.
Adult is not indicated for use in pediatric patients below the age of 11 years
